Insider · CIK 0001767009

Nicholson Ryan

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001767009

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-25	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−1,183 sh	$65.28	−$77.2K	34,453
2026-08-10	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−1,348 sh	$62.04	−$83.6K	35,636
2026-08-04	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−357 sh	$60.63	−$21.6K	36,984
2026-02-13	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+2,667 sh	$45.50	+$121K	39,623
2026-02-13	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−2,667 sh	$66.38	−$177K	36,956
2026-02-13	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−2,667 sh	—	—	0
2025-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−649 sh	$66.62	−$43.2K	36,956
2025-12-15	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+9,032 sh	—	—	39,140
2025-12-15	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−1,535 sh	$67.54	−$104K	37,605
2025-02-05	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+7,000 sh	$33.15	+$232K	36,758
2025-02-05	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−7,000 sh	$84.07	−$588K	29,758
2025-02-05	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−7,000 sh	—	—	0
2024-12-16	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+7,328 sh	—	—	31,692
2024-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−1,934 sh	$79.18	−$153K	29,758
2024-11-26	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+10.5K sh	$31.73	+$333K	34,864
2024-11-26	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−10.5K sh	$80.18	−$842K	24,364
2024-11-26	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−10.5K sh	—	—	0
2023-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−195 sh	$87.49	−$17.1K	24,078
2023-12-15	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+6,253 sh	—	—	25,623
2023-12-15	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−1,350 sh	$88.60	−$120K	24,273
2023-02-06	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+3,025 sh	$42.98	+$130K	22,392
2023-02-06	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+3,600 sh	$37.35	+$134K	25,992
2023-02-06	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−6,625 sh	$84.56	−$560K	19,367
2023-02-06	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−354 sh	$84.56	−$29.9K	19,013
2023-02-06	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−3,025 sh	—	—	0
2023-02-06	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−3,600 sh	—	—	0
2022-12-19	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−217 sh	$70.80	−$15.4K	19,367
2022-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−195 sh	$71.07	−$13.9K	19,584
2022-12-15	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−780 sh	$73.17	−$57.1K	13,190
2022-12-15	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+6,589 sh	—	—	19,779
2021-12-17	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−217 sh	$92.00	−$20K	13,685
2021-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−195 sh	$91.80	−$17.9K	13,902
2021-12-15	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−661 sh	$90.55	−$59.9K	9,597
2021-12-15	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+4,500 sh	—	—	14,097
2021-08-16	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−364 sh	$101.03	−$36.8K	10,186
2021-08-16	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+2,900 sh	$30.49	+$88.4K	13,086
2021-08-16	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−2,900 sh	$101.06	−$293K	10,186
2021-08-16	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−2,900 sh	—	—	0
2021-02-03	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−2,237 sh	$91.01	−$204K	10,223
2020-12-17	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−217 sh	$91.03	−$19.8K	12,460
2020-12-16	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−195 sh	$92.08	−$18K	12,677
2020-12-15	DLBDolby Laboratories, Inc.F Tax Payment	VP, CAO and Corp. Controller	FTax Payment	−444 sh	$90.86	−$40.3K	8,372
2020-12-15	DLBDolby Laboratories, Inc.A Award	VP, CAO and Corp. Controller	AAward	+4,500 sh	—	—	12,872
2020-08-26	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−506 sh	$70.67	−$35.8K	8,789
2020-08-26	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+395 sh	$28.24	+$11.2K	9,184
2020-08-26	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−395 sh	$70.62	−$27.9K	8,789
2020-08-26	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	−395 sh	—	—	0
2020-02-11	DLBDolby Laboratories, Inc.M Exercise/Conversion	VP, CAO and Corp. Controller	MExercise/Conversion	+1,740 sh	$25.00	+$43.5K	11,851
2020-02-11	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−1,740 sh	$71.63	−$125K	10,111
2020-02-11	DLBDolby Laboratories, Inc.S Sale	VP, CAO and Corp. Controller	SSale	−1,180 sh	$71.59	−$84.5K	8,931

Recent filings

Accepted (ET)
Aug 274
Nicholson Ryan0001193125-26-371803
SEC(opens sec.gov)
Aug 124
Nicholson Ryan0001193125-26-346962
SEC(opens sec.gov)
Aug 64
Nicholson Ryan0001193125-26-338476
SEC(opens sec.gov)
Feb 174
Nicholson Ryan0001193125-26-055254
SEC(opens sec.gov)
Dec 174
Nicholson Ryan0001193125-25-323440
SEC(opens sec.gov)
Feb 64
Nicholson Ryan0000950170-25-015672
SEC(opens sec.gov)
Dec 184
Nicholson Ryan0000950170-24-138174
SEC(opens sec.gov)
Nov 274
Nicholson Ryan0000950170-24-131570
SEC(opens sec.gov)
Dec 194
Nicholson Ryan0001209191-23-059256
SEC(opens sec.gov)

Companies

Dolby Laboratories, Inc.VP, CAO and Corp. ControllerDLB

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103